« BackThe Journal of Arthroplasty
Article in Press

Costs Related to Hip Disease in Patients Eligible for Total Hip Arthroplasty

  • Ola Rolfson, MD, PhD

      Affiliations

    • Department of Orthopedics, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Sweden
    • Corresponding Author InformationReprint requests: Ola Rolfson, MD, Sahlgrenska University Hospital/Mölndal, SE-431 82 Mölndal, Sweden.
    • ,
  • Oskar Ström, MSc

      Affiliations

    • Medical Management Centre, Karolinska Institute, Stockholm, Sweden
    • ,
  • Johan Kärrholm, MD, PhD

      Affiliations

    • Department of Orthopedics, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Sweden
    • ,
  • Henrik Malchau, MD, PhD

      Affiliations

    • Department of Orthopedics, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • Göran Garellick, MD, PhD

      Affiliations

    • Department of Orthopedics, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Sweden

Received 26 September 2010; received in revised form 10 June 2011; accepted 7 September 2011. published online 03 January 2012.
Corrected Proof

Abstract 

This study was designed to estimate direct and indirect costs incurred by hip disease in patients eligible for total hip arthroplasty (THA). Before THA, 2635 patients completed a questionnaire regarding the use of resources because of their hip disease. Costs were assigned using official statistical sources or market prices. Annual costs amounted to US$ 7666 per patient. In a regression analysis, higher annual costs were associated with working age, female gender, comorbidity, and operation waiting time more than 90 days (P < .005). The burden of disease for THA candidates is extensive, where loss of productivity is the principal cost. Long wait for surgery is associated with increased costs. This study provides baseline cost data, which will be useful for further health economic analyses and could provide guidance for health care decision makers.

Keywords: cost of illness, hip disease, hip osteoarthritis, waiting time, total hip arthroplasty

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The Conflict of Interest statement associated with this article can be found at doi:10.1016/j.arth.2011.09.030.

PII: S0883-5403(11)00624-3

doi:10.1016/j.arth.2011.09.030

« BackThe Journal of Arthroplasty

Article Tools

* Image Usage & Resolution